Marshall Wace

Marshall Wace’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Marshall Wace’s Portfolio RETA Stock Details RETA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell
2023 Q2	$8.62M	Sell
2023 Q1	$37.7M	Buy
2022 Q4	$7.8M	Buy
2022 Q3	$302K	Buy
2021 Q1	–	Sell
2020 Q4	$1.3M	Buy
2020 Q3	$675K	Buy
2018 Q2	–	Sell
2018 Q1	$217K	Buy